Bob Wise

Bob Wise is the CEO of SOLIUS, a Seattle-based biotechnology company that develops light therapy technologies designed to stimulate vitamin D production in the skin using a narrow spectrum of UVB light. He is an experienced operations and financial executive whose prior roles include President of Healthcare at Nuance Communications and EVP of Corporate Development at MarchFIRST. Under his leadership, SOLIUS has pursued research into the health impacts of vitamin D, including its potential role in supporting immune function.